Cronos Group Inc. Announces Results of Vote for Election of Directors
June 19 2019 - 6:17PM
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“
Cronos
Group” or the “
Company”) reports that at
its Annual Meeting of Shareholders on June 19, 2019 there were 610
shareholders voting in person or by proxy holding in total
261,290,314 common shares, representing 78.2% of the total number
of common shares outstanding.
Each of the directors listed as a nominee in the
management proxy circular dated May 8, 2019 was elected to serve as
a director of the Company until the next annual meeting. The
results of the vote for the election of directors are as
follows:
Name of Director |
Number of Shares Voted For* |
Percentage of Shares Voted For |
Number of Shares Withheld from Voting* |
Percentage of Shares Withheld from Voting |
Jason Adler |
183,807,372 |
99.75% |
459,017 |
0.25% |
Kevin C. Crosthwaite, Jr. |
178,988,142 |
97.14% |
5,278,247 |
2.86% |
Bronwen Evans |
183,745,229 |
99.72% |
521,160 |
0.28% |
Murray R. Garnick |
180,124,077 |
97.75% |
4,142,312 |
2.25% |
Bruce A. Gates |
180,134,640 |
97.76% |
4,131,749 |
2.24% |
Michael Gorenstein |
179,747,903 |
97.55% |
4,518,486 |
2.45% |
James Rudyk |
180,525,486 |
97.97% |
3,740,903 |
2.03% |
* As the vote for each motion was taken by ballot, the number of
votes disclosed reflects the votes submitted by ballot at the
meeting.
About Cronos GroupCronos
Group is an innovative global cannabinoid company with
international production and distribution across five
continents. Cronos Group is committed to building disruptive
intellectual property by advancing cannabis
research, technology and product development. With a
passion to responsibly elevate the consumer
experience, Cronos Group is building an iconic brand
portfolio. Cronos Group’s portfolio includes PEACE
NATURALS™, a global health and wellness
platform, and two adult-use brands, COVE™ and Spinach™.
To learn more about Cronos Group and its brands, please
visit: www.thecronosgroup.com; www.peacenaturals.com; www.covecannabis.ca; www.spinachcannabis.com.
Forward-looking statementsThis
news release contains “forward-looking information” and
“forward-looking statements” within the meaning of applicable
Canadian and U.S. securities laws. All information contained
herein that is not clearly historical in nature may constitute
forward-looking information. In some cases, forward-looking
statements can be identified by words or phrases such as “may”,
“will”, “expect”, “plan”, “anticipate”, “intend”, “potential”,
“estimate”, “believe” or the negative of these terms, or other
similar expressions intended to identify forward-looking
statements. Some of the forward-looking statements contained in
this press release include the Company’s intention to build an
international iconic brand portfolio and develop disruptive
intellectual property. Forward-looking statements are necessarily
based upon a number of estimates and assumptions that, while
considered reasonable by management, are inherently subject to
significant business, economic and competitive risks, uncertainties
and contingencies that may cause actual financial results,
performance or achievements to be materially different from the
estimated future results, performance or achievements expressed or
implied by those forward-looking statements and the forward-looking
statements are not guarantees of future performance. A discussion
of some of the material risks applicable to the Company can be
found in the Company’s current Management’s Discussion and Analysis
and Annual Information Form, both of which have been filed on SEDAR
and EDGAR and can be accessed
at www.sedar.com and www.sec.gov/edgar,
respectively. The forward-looking information included in this news
release is made as of the date of this news release and, except as
required by law, Cronos Group disclaims any obligation to
update or revise any forward-looking statements. Readers are
cautioned not to put undue reliance on these forward-looking
statements.
For further information please
contact:Anna Shlimak Investor Relations Tel: (416)
504-0004 investor.relations@thecronosgroup.com
Cronos (NASDAQ:CRON)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cronos (NASDAQ:CRON)
Historical Stock Chart
From Sep 2023 to Sep 2024